General Range
MUCETUNE-AB
Price on request/100 · MOQ 100 boxes
MUCETUNE-AB Tablets by Fortune Labs contain Acebrophylline and Acetylcysteine, a combination formulated to support respiratory health and manage conditions associated with excessive mucus production. Acebrophylline has bronchodilator and mucus-regulating properties that may help improve airflow, while Acetylcysteine is a mucolytic agent that helps thin thick mucus, making it easier to clear from the airways. MUCETUNE-AB may be prescribed for chronic bronchitis and Chronic Obstructive Pulmonary Disease (COPD) when clinically appropriate. Available in convenient 10 × 10 tablet blister packaging, this product is part of Fortune Labs' respiratory pharmaceutical portfolio. Fortune Labs offers Respiratory PCD Pharma Franchise and distribution opportunities across India. Contact the company for wholesale pricing, product availability, and franchise enquiries. Use only under medical supervision.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Acebrophylline + Acetylcysteine Tablets
- Packaging Type
- Blister Pack with Outer Carton
- Packaging Size
- 10 × 10
- Dosage Form
- Tablet
- Treatment
- Chronic Obstructive Pulmonary Disease (COPD), chronic bronchitis, excessive mucus production, chest congestion, and breathing difficulties associated
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
